COMBINING A NOVEL DUAL RAF/MEK INHIBITOR WITH IMMUNOMODULATION TO PROMOTE AN ANTI-TUMOR RESPONSE

被引：0
|
作者：
Dong, Lauren [1 ]
Choi, Hyejin [1 ]
Budhu, Sadna [1 ]
Schulze, Isabell [1 ]
Mehanna, Nezar [1 ]
Rosen, Neal [1 ]
Merghoub, Taha [1 ]
Wolchok, Jedd [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
604
引用
收藏
页码：A634 / A634
页数：1
相关论文
共 50 条
  • [41] MEK162 (ARRY-162), a novel MEK 1/2 inhibitor, inhibits tumor growth regardless of KRas/Raf pathway mutations
    Winski, S.
    Anderson, D.
    Bouhana, K.
    Impastato, R.
    Woessner, R.
    Zuzack, J.
    Tunquist, B.
    Garrus, J.
    Pheneger, T.
    Lee, P.
    EJC SUPPLEMENTS, 2010, 8 (07): : 56 - 56
  • [42] EXPLORING ANTI-TUMOR EFFECTS OF SMALL MOLECULE INHIBITORS OF CDK4/6, FAK, AND RAF/MEK IN PRECLINICAL MODELS OF MENINGIOMA
    Ijad, Nazanin
    Waller, Katie L.
    Nayyar, Naema
    Larson, Juliana M.
    Spear, Joshua
    Cahill, Daniel
    Barker, Frederick G.
    Galanis, Evanthia
    Sarkaria, Jann
    Wakimoto, Hiroaki
    Vaubel, Rachael
    Brastianos, Priscilla
    NEURO-ONCOLOGY, 2022, 24 : 230 - 230
  • [43] Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity
    Bolf, Eric. L. L.
    Beadnell, Thomas. C. C.
    Rose, Madison. M. M.
    D'Alessandro, Angelo
    Nemkov, Travis
    Hansen, Kirk. C. C.
    Schweppe, Rebecca. E. E.
    CELLS, 2023, 12 (10)
  • [44] A novel polyamine blockade therapy activates an anti-tumor immune response
    Alexander, Eric T.
    Minton, Allyson
    Peters, Molly C.
    Phanstiel, Otto
    Gilmour, Susan K.
    ONCOTARGET, 2017, 8 (48) : 84140 - 84152
  • [45] Targeting macrophages to promote anti-tumor immunity.
    Varner, Judith A.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
  • [46] The immune system as anti-tumor sentinel: Molecular requirements for an anti-tumor immune response
    Markiewicz, MA
    Gajewski, TF
    CRITICAL REVIEWS IN ONCOGENESIS, 1999, 10 (03): : 247 - 260
  • [47] Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene
    Boileau, Marie
    Descarpentries, Clotilde
    Delzenne, Guillaume
    Trentesaux, Victorine
    Greliak, Anna
    Jamme, Philippe
    Marchetti, Philippe
    Mortier, Laurent
    MELANOMA RESEARCH, 2023, 33 (03) : 247 - 251
  • [48] Dual antitumor immunomodulatory effects of PARP inhibitor on the tumor microenvironment: A counterbalance between anti-tumor and pro-tumor
    Yi, Xiao-Fang
    Gao, Ruo-Lin
    Sun, Li
    Wu, Zhi-Xuan
    Zhang, Shu-Ling
    Huang, Le-Tian
    Han, Cheng-Bo
    Ma, Jie-Tao
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 163
  • [49] Involvement of eosinophils in the anti-tumor response
    Solène Gatault
    Fanny Legrand
    Marie Delbeke
    Sylvie Loiseau
    Monique Capron
    Cancer Immunology, Immunotherapy, 2012, 61 : 1527 - 1534
  • [50] Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity
    Tzeng, Hong-Tai
    Huang, Yu-Jie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
12345